Sevda Zamanova

Sevda Zamanova

Auto-generated profile, based on publicly available information

Sevda Zamanova

Department of Obstetrics and Gynecology, VM Medical Park Maltepe Hospital, 34846 Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2024 in Acta Medica Nicomedia
Verified
Journal Article
Open access
PDF file
SZSevda Zamanova
Sevda Zamanova
SSSunullah Soysal
Sunullah Soysal
MDMerve Demir
Merve Demir
Objective: To examine the effect of antenatal corticosteroid administration on umbilical artery (UA) Doppler measurements in pregnancies complicated with fetal growth restriction (FGR). Methods: This cross-sectional study was conducted with 149 pregnant women scheduled for antenatal corticosteroid therapy because of the possibility of preterm birth. UA Doppler measurements (PI, S/D ratio, RI) before antenatal corticosteroid administration and 24 and 48 hours after the last dose of corticosteroid administration were evaluated and compared with each other in pregnant groups complicated with FGR and uncomplicated with FGR. Results: No statistically significant change was observed in UA Doppler parameters 24 and 48 hours after antenatal corticosteroid treatment in each group with and without FGR. While there was no significant difference between the precorticosteroid UA Doppler parameters (PI, S/D ratio, RI) of the two groups with and without FGR, the values of these parameters 24 hours after the last dose of treatment were statistically higher in the group complicated with FGR than in the uncomplicated group. However, no statistical difference was observed in UA Doppler parameters between the two groups 48 hours after the last dose of treatment. Conclusion: Antenatal corticosteroid does not permanently affect UA Doppler parameters in the case of FGR. Close monitoring of the fetus for 72 hours after the first dose of antenatal corticosteroid may be helpful in pregnant women complicated by FGR.

21 April 2026 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
MDMerve Demir
Merve Demir
ESEmre Sertel
Emre Sertel
ÇYÇağcıl Yetim
Çağcıl Yetim
SZSevda Zamanova
Sevda Zamanova
DADursun Emre Aydın
Dursun Emre Aydın
Background: Early detection of fetal developmental abnormalities can allow for necessary precautions to be taken to reduce risks that may arise during and after birth. This study aimed to investigate the association between first-trimester aneuploidy screening markers—pregnancy-associated plasma protein A (PAPP-A), free beta-human chorionic gonadotropin (fβ-hCG), and nuchal translucency (NT)—and neonatal anthropometric measurements (weight, length, and head circumference). It also evaluated their predictive value for subsequent fetal growth abnormalities, including small for gestational age (SGA) and large for gestational age (LGA) births. Methods: This retrospective study included 422 singleton pregnant women and their newborns. First-trimester NT, fβ-hCG, and PAPP-A multiple of the median (MoM) values were compared among mothers who delivered SGA, appropriate for gestational age (AGA), and LGA infants. Correlations between these markers and neonatal percentiles for weight, length, and head circumference were also examined. Results: Mothers of SGA neonates had significantly lower PAPP-A and fβ-hCG MoM values than mothers of AGA or LGA neonates (p < 0.05). Receiver operating characteristic (ROC) analysis demonstrated moderate discriminatory performance for the identification of pregnancies at increased risk of SGA, with an area under the curve (AUC) of 0.687 for fβ-hCG MoM (p < 0.001) and 0.674 for PAPP-A MoM (p = 0.001). Spearman correlation analysis showed that PAPP-A MoM was positively correlated with neonatal birth weight (r = 0.133, p = 0.006) and length percentiles (r = 0.151, p = 0.002). fβ-hCG MoM was also positively correlated with neonatal weight (r = 0.151, p = 0.002), length (r = 0.114, p = 0.019), and head circumference percentiles (r = 0.104, p = 0.032). Correlation analysis revealed no significant association between NT MoM and neonatal anthropometric measurements. In multivariable logistic regression analysis, lower first-trimester PAPP-A MoM (adjusted odds ratio [aOR]: 2.51) and fβ-hCG MoM (aOR: 2.95) remained independently associated with SGA, whereas NT MoM did not. Conclusions: First-trimester PAPP-A and fβ-hCG values were significantly lower in mothers who delivered SGA infants and showed moderate discriminatory ability for the identification of pregnancies at increased risk of SGA. In addition, first-trimester PAPP-A and fβ-hCG levels were correlated with neonatal birth weight and length, and first-trimester fβ-hCG levels were also correlated with neonatal head circumference. In contrast, first-trimester NT was not associated with neonatal anthropometric outcomes.